Awards Nomination 20+ Million Readerbase
Indexed In
  • Academic Journals Database
  • Open J Gate
  • Genamics JournalSeek
  • JournalTOCs
  • China National Knowledge Infrastructure (CNKI)
  • Scimago
  • Ulrich's Periodicals Directory
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Publons
  • MIAR
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
Share This Page
Emerging partners for emerging markets: Utilizing regional vaccine licensing & technology transfer strategies
International Conference & Exhibition on Vaccines & Vaccination
22-24 Nov 2011 Philadelphia Airport Marriott, USA

Steven M. Ferguson

Accepted Abstracts: J Vaccines Vaccin

Abstract:

With the rise of vaccine manufacturers in countries such as China, India and other areas of the world, it is becoming increasingly apparent that it is longer an absolute requirement to rely upon a single company partner to develop a specifi c vaccine product on a global basis. Utilizing their substantial internal markets, growing manufacturing capacities and increased product development experience, regional vaccine manufacturers off er an �alternative� business development strategy for new technologies other than that of the �one size fi ts all� global multi- national fi rms. Th is strategy may be particularly useful where the medical needs may be more pressing in regional markets rather than in the typical U.S. and European pharmaceutical ones. In the area of vaccines, for example, the National Institutes of Health has been able to complete 14 agreements for six diff erent products in India alone with multiple developmental partners with additional agreements completed with fi rms in China, Brazil, Vietnam and Korea. Attendees will gain a sense of how this regional licensing approach can work based upon the experience of the National Institutes of Health. Hopefully this will generate some creative ideas by attendees for their own product development projects and generate a faster global presence for their future vaccine products

Biography :

Steven M. Ferguson currently serves as a Deputy Director and senior licensing professional for the NIH Of fi ce of Technology Transfer, the patent & licensing of fi ce for technologies arising from the NIH and FDA research programs. Mr. Ferguson holds Master?s Degrees in Business Administration (George Washington University) and Chemistry (University of Cincinnati).A registered Patent Agent and a Certi fi ed Licensing Professional (CLP), Mr. Ferguson is also serves as Technology Transfer Department Chair at the Foundation for Advanced Education in the Sciences (FAES) Graduate School at NIH. Mr. Ferguson has published numerous articles on licensing and technology transfer. He has received the AUTM President?s Award, the NIH Director?s Award, the FAES Instruction Award and twelve NIH Merit Awards in recognition of his service and activities in the area of technology transfer.